Once the down-regulation of MEG3 and linc-PINT was confirmed in B and T-ALL cell lines, we evaluated their expression in 29 primary B-ALL and 11 primary T-ALL samples versus B or T lymphocytes purified from PBHD. The gene discussed is LINC-PINT; the disease is acute lymphoblastic leukemia.